Skip to main content
Sign In
 

Tracey Schefter Publications


 

Publications:

 

 

1.         Kavanagh BD, Schefter TE, Wu Q, Tong S, Newman F, Arnfield M, Benedict SH, McCourt S, Mohan R. Clinical Application of Intensity-Modulated Radiotherapy for Locally Advanced Cervical Cancer.  Seminars in Radiation Oncology. 12(3):260-71, 2002

 

2.         Schefter TE, Kavanagh, BK, Wu Q, Tong S, Newman F, McCourt S, Arnfield M, Benedict S, Mohan R.  Technical Considerations in the Application of Intensity-Modulated Radiotherapy as a Concomitant Integrated Boost for Locally Advanced Cervix Cancer. Medical Dosimetry. 27(2):177-84, 2002

 

3.         Kavanagh BD, Timmerman RD,  Benedict SH, Wu Q, Schefter TE, Stuhr K, McCourt S, Newman F, Cardinale RM, Gaspar LE. How Should We Describe the Radiobiologic Effect of  Extracranial Stereotactic Radiosurgery:  Equivalent Uniform Dose or Tumor Control Probability? Med Phys 2003 Mar; 30(3):321-4.

 

4.         Singh M, Davidson S, Schefter T, Bell.  Immature Teratoma:Second Opinion Case Discussion. Oncology.  18(4):474-477. 2004

 

5.         Song DY, Kavanagh BD, Benedict SH, Schefter TE. Stereotactic Body Radiation Therapy: Rationale, Techniques, Applications, and Optimization of an Emerging Technology.  Oncoology.  18(4):474-477. 2004

 

6.         Kelsey CR**, Schefter TE, Nash R, Russ P, Baron AE, Zeng C, Gaspar LE.  Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for stereotactic body radiotherapy. The American Journal of Clinical Oncology. 2005. 28:576-580.  **Duke University Resident, Schefter mentored research 

 

7.         Schefter TE, Kavanagh BD, Timmerman RD, Cardenes H, Baron A, Gaspar LE.  Phase I Trial of Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases.  Int J Radiat Oncol Biol Phys. 2005. 62(5):1371-1378.

 

8.         Schefter TE, Patel M**, McCarter M, et al. Triple Modality Therapy for a Young Woman with Locally Advanced Thoracic Esophageal Adenocarcinoma.  Part I. Oncology. 19(6): 775-779 May, 2005.  **Edmonton (Canada) University Resident, Schefter mentored research 

 

9.         Schefter TE, Patel M, McCarter M, et al. Triple Modality Therapy for a Young Woman with Locally Advanced Thoracic Esophageal Adenocarcinoma.  Part II. Oncology.  19(7): 830-845. June, 2005.

 

 

10.       Schefter TE, Kavanagh BD, Raben D, et al. A Phase I Trial of Stereotactic Body Radiation Therapy (SBRT) for Lung Metastases. Int J Radiat Oncol Biol Phys. 2006. 66(4) supplement. S120-127.

 

11        Kavanagh BD, Schefter TE, Wersäll JP. Stereotactic Body Radiation Therapy for Liver, Renal, and Retroperitoneal Tumors. Front Radiat Ther Oncol. 2007. 40: 415-426.

 

12.       Kavanagh B, Ding M, Schefter T, Stuhr K, Newman F. The dosimetric effect of inhomogeneity correction in dynamic conformal arc stereotactic body radiation therapy for lung tumors. J Appl Clin Med Phys. 7(2): 58-63, 2006.

 

13.       Kavanagh BD, Schefter TE, Cardenes HR, et al.  Interim analysis of a prospective phase I/II trial of SBRT for liver metastases.  Acta Oncologica. 2006. 45:848-855.

 

14.       Small W, Mell LK, Anderson P, Creutzberg C, De Los Santos J, Gaffney D, Jhingran A, Portelance L, Schefter T, Iyer R, Varia M, Winter K, Mundt AJ. Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiotherapy in Postoperative Treatment of Endometrial and Cervical Cancer. . Int J Radiat Oncol Biol Phys. 2007. 71(2):428-434.  [Epub ahead of print].

 

15.       Kavanagh BD, Schefter TE, Wersall PJ. Liver, renal, and retroperitoneal tumors: stereotactic radiotherapy. Frontiers of Radiation Therapy & Oncology. 40:415-26, 2007.

 

16.       Ballonoff A**, Kavanagh, BD, McCarter, Kane M, Pearlman N, Nash R,  Shah RJ, Raben D, Schefter TE.; Phase II trial of preoperative capecitabine and accelerated Intensity Modulated Radiotherapy in locally advanced rectal cancer. AJCO.31:264-270. 2008.   ** Radiation oncology resident, mentored research.

 

17.       McCammon R, Schefter TE, Zaemisch R, et al. Observation of a dose-control relationship for extra-cranial tumors after Stereotactic Body Radiation Therapy (SBRT). Int J Radiat Oncol Biol Phys. 73(1):112-118. 2009.

 

18.       Schwer AL**, Ballonoff A**, McCammon R**, Rusthoven K**, B D’Agostino Jr. RB,   and Schefter TE.  Survival Impact of Neoadjuvant Radiotherapy Prior to Esophagectomy for Patients with Esophageal Cancer: A Surveillance, Epidemiology, and End- Results (SEER) Study. Int J Radiat Oncol Biol Phys. 73(2):449-455. 2009. Selected for “Issue Highlights”.  ** Radiation oncology resident, mentored research

 

19.       Olsen C**, Schefter TE,  Leong S,  Kane M, McCarter M, Chen H, Wachs M, Eckhardt G, Stiegmann G, Raben D. Serum Kras as a Marker For Response To Gefitinib, Paclitaxel, and Radiation Therapy in Patients with Locally Advanced Pancreatic Cancer: Analysis and Phase I Trial Results. AJCO. 32(2): 115-121. April 2009.   ** Radiation oncology resident, mentored research.

 

20.       Olsen CC**, Welsh J**, Kavanagh BD, Franklin W, McCarter M, Cardenes HR**, Gaspar LE and  Schefter TE.  Microscopic and Macroscopic Tumor and Parenchymal Effects of Liver Stereotactic Body Radiation Therapy.  Int J Radiat Oncol Biol Phys. 73(5):1414-1424. 2009. Selected for “Issue Highlights”.   ** Radiation oncology resident, mentored research, Welsh: University of AZ, Olsen, University of Colorado.

 

21.       Rusthoven K**, Kavanagh BD,  Cardenes H, Stieber VW,  Burri S, Feigenberg SJ, Chidel M, Pugh Franklin W,  T, Kane M, Gaspar LG, Schefter TE. Mature Results of a Multi-Institutional Phase  I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases.  JCO. 27(10):1572-1578. 2009.   ** Radiation oncology resident, mentored research

 

22.       Rusthoven K**, Kavanagh BD, Burri S, Chen C, Cardenes H, Chidel M, Pugh T, Kane M,  Gaspar  LG, Schefter TE. Mature Results of a Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases. JCO. 27(10):1579-1584. 2009.    ** Radiation oncology resident, mentored research

 

23.       Dunlap NE, Cai J, Biedermann GB, Yang W, Benedict SH, Sheng K, Schefter TE, Kavanagh BD, Larner M.  Chest Wall Volume Dosage Predicts Risk of Severe Pain and/or Rib Fracture Following Lung Stereotactic body Radiation Therapy.  Int J Radiat Oncol Biol Phys. ePUB ahead of press. May 2009.

 

24.       Cárdenes HR, Price TR, Perkins SM, Maluccio M, Kwo P, Breen TE, Henderson MA, Schefter TE,Tudor K, Deluca J and. Johnstone PA. Phase I Trial of Stereotactic Body Radiation Therapy For Primary Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys. Submitted Oct 2009.

 

25.       Schefter TE and Kavanagh BK.  Response to  X Mirabel “Have we established an SBRT regimen for liver metastases?”.  JCO. 27(22):e41.

 

26.       Chen Y, Newman F and Schefter TE. Radiation Dose Perturbations Adjacent to Esophageal Metallic Stents in a Phantom. Gastrointestinal Endoscopy journal. Submitted Oct 2009.

 

27.       Buyyounouski MK, Price RA, Harris ER, Milller R, Tome W, Schefter TE, Parsai I, Konski AA, Wallner PE.  Stereotactic Body Radiotherapy (SBRT) For Primary Management of Early-Stage, Low-Intermediate Risk Prostate Cancer:  Report of the ASTRO Emerging Technology Committee (ETC). Int J Radiat Oncol Biol Phys. In press Oct 2009.

 

28.       Cervical Cancer State-of-the-Clinical-Science Meeting on Pretreatment Evaluation and Prognostic Factors, September 27-28, 2007: proceedings and research recommendations (NCI, ASTRO, RTOG). 1st author: Trimble E, contributor: Schefter TE. Gyn Oncology. In press Oct 2009.

 

29.       Garofalo M and Schefter TE. IMRT for Rectal Cancer: A review. Radiation Medicine Rounds. In Press Dec 2009.

 

Book Chapters: 

1.       Schefter T and Rabinovitch R. Renal Cell Carcinoma.  Radiation Oncology. Leibel, Philips, edition 2. 2002

 

2.         Schefter T. Radiation Injury. The Merck Manual of Medical Information-Home Edition. Edition 2. 2003

 

3.         Schefter TE, Kavanagh BD.  Cervical Cancer IMRT chapter 23.1.  Intensity Modulated Radiation Therapy: A Clinical Perspective. Mundt AJ, Roeske JC. 2005.

 

4.         Schefter TE, Cardenes H. SBRT for primary and metastatic liver tumors.  Stereotactic Body Radiation Therapy.  Kavanagh BD, Timmerman R. Lippincott, Williams, & Wilkins. 2004.

 

5.         Schefter TE, Cardenes H.  Liver SBRT Case Studies.  Stereotactic Body Radiation Therapy.  Editors: Kavanagh BD, Timmerman R. Lippincott, Williams, & Wilkins. 2004.

 

6.         Gaspar LE, Schefter TE. IASLC Textbook, Chapter 17, Non-surgical Approaches to Screened Detected Lesions.  Editors: Fred R Hirsch, Paul A Bunn, Haribumi Kato, James L Mulshine.  2005.

 

7.         Kavanagh BD, Schefter TE, Wersall PJ.  IMRT, IGRT, SBRT: Advances in the Treatment Planning and Delivery of Radiotherapy. Liver, Renal, and Retroperitoneal Tumors. Editor: John Meyer.  2007.